Apixaban in Patients with Atrial Fibrillation

被引:0
作者
Lynch, Donald R., Jr. [1 ]
机构
[1] Johns Hopkins Univ Hosp, Baltimore, MD 21287 USA
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:2362 / 2363
页数:2
相关论文
共 50 条
  • [22] Efficacy and Safety of Apixaban in the Patients Undergoing the Ablation of Atrial Fibrillation
    Nagao, Tomoyuki
    Inden, Yasuya
    Shimano, Masayuki
    Fujita, Masaya
    Yanagisawa, Satoshi
    Kato, Hiroyuki
    Ishikawa, Shinji
    Miyoshi, Aya
    Okumura, Satoshi
    Ohguchi, Shiou
    Yamamoto, Toshihiko
    Yoshida, Naoki
    Hirai, Makoto
    Murohara, Toyoaki
    [J]. PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY, 2015, 38 (02): : 155 - 163
  • [23] Relationship of Warfarin and Apixaban with Vascular Function in Patients with Atrial Fibrillation
    Junejo, Rehan T.
    Gupta, Dhiraj
    Snowdon, Richard L.
    Lip, Gregory Y. H.
    Fisher, James P.
    [J]. JOURNAL OF VASCULAR RESEARCH, 2024, 61 (02) : 59 - 67
  • [24] Effectiveness and Safety of Apixaban Versus Rivaroxaban for Patients With Atrial Fibrillation
    不详
    [J]. ANNALS OF INTERNAL MEDICINE, 2020, 172 (07) : 463 - 473
  • [25] Net clinical benefit of apixaban among patients with atrial fibrillation
    Pisters, R.
    Nieuwlaat, R.
    Lane, D. A.
    Crijns, H. J. G. M.
    Lip, G. Y. H.
    [J]. EUROPEAN HEART JOURNAL, 2012, 33 : 58 - 58
  • [26] Apixaban in patients at risk of stroke undergoing atrial fibrillation ablation
    Kirchhof, Paulus
    Haeusler, Karl Georg
    Blank, Benjamin
    De Bono, Joseph
    Callans, David
    Elvan, Arif
    Fetsch, Thomas
    Van Gelder, Isabelle C.
    Gentlesk, Philip
    Grimaldi, Massimo
    Hansen, Jim
    Hindricks, Gerhard
    Al-Khalidi, Hussein R.
    Massaro, Tyler
    Mont, Lluis
    Nielsen, Jens Cosedis
    Noelker, Georg
    Piccini, Jonathan P.
    De Potter, Tom
    Scherr, Daniel
    Schotten, Ulrich
    Themistoclakis, Sakis
    Todd, Derick
    Vijgen, Johan
    Di Biase, Luigi
    [J]. EUROPEAN HEART JOURNAL, 2018, 39 (32) : 2942 - 2955
  • [27] Major Bleeding in Patients With Atrial Fibrillation Receiving Apixaban or Warfarin
    Hylek, Elaine M.
    Held, Claes
    Alexander, John H.
    Lopes, Renato D.
    De Caterina, Raffaele
    Wojdyla, Daniel M.
    Huber, Kurt
    Jansky, Petr
    Steg, Philippe Gabriel
    Hanna, Michael
    Thomas, Laine
    Wallentin, Lars
    Granger, Christopher B.
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2014, 63 (20) : 2141 - 2147
  • [28] COST EFFECTIVENESS OF APIXABAN COMAPRED TO ASPIRIN IN PATIENTS WITH ATRIAL FIBRILLATION
    Ademi, Z.
    Pasupathi, K.
    Liew, D.
    [J]. VALUE IN HEALTH, 2014, 17 (03) : A117 - A117
  • [29] Apixaban, Rivaroxaban, and Dabigatran in Patients Undergoing Atrial Fibrillation Ablation
    Rillig, Andreas
    Lin, Tina
    Plesman, Joaquina
    Heeger, Christian-H.
    Lemes, Christine
    Metzner, Andreas
    Mathew, Shibu
    Wissner, Erik
    Wohlmuth, Peter
    Ouyang, Feifan
    Kuck, Karl-Heinz
    Tilz, Roland Richard
    [J]. JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY, 2016, 27 (02) : 147 - 153
  • [30] A New Coagulant for Atrial Fibrillation: Apixaban
    不详
    [J]. TURKISH JOURNAL OF NEUROLOGY, 2013, 19 (01) : 37 - 37